What is the difference between Cyltezo and Humira?
Cyltezo (adalimumab-adbm) is an Interchangeable biosimilar to Humira (adalimumab), an anti-TNF-α monoclonal antibody used for the treatment of multiple conditions including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, plaque psoriasis, hidradenitis suppurativa, and uveitis.
A biosimilar is a product that is highly similar to an FDA-approved biologic, known as the reference product. Biosimilars have no clinically meaningful differences in safety, purity or potency compared to the reference product.
To achieve the interchangeable designation, the FDA requires an Interchangeability study, which is an additional clinical study of multiple substitutions in patients to show how patients do when they are switched back and forth multiple times from a reference product to the Interchangeable biosimilar.
A biosimilar with an Interchangeable designation can be auto-substituted by a pharmacist for the reference product, with individual state laws controlling how and whether physicians will be notified.
Cyltezo (adalimumab-adbm) was the second Humira (adalimumab) biosimilar approved by the FDA.
FDA approved biosimilars to Humira include:
- Amjevita (adalimumab-atto)
- Cyltezo (adalimumab-adbm)
- Hyrimoz (adalimumab-adaz)
- Hadlima (adalimumab-bwwd)
- Abrilada (adalimumab-afzb)
- Hulio (adalimumab-fkjp)
- Yusimry (adalimumab-aqvh)
- Yuflyma (adalimumab-aaty)
The approved indications for Humira and Cyltezo are the same, with variations in population groups.
Like Humira, Cyltezo is used for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.
The following table compares the approved indications for Humira and Cyltezo:
Indication | Humira | Cyltezo |
---|---|---|
Rheumatoid Arthritis (RA) | adults | adults |
Juvenile Idiopathic Arthritis (JIA) |
patients 2 years of age and older |
patients 2 years of age and older |
Psoriatic Arthritis (PsA) | adults | adults |
Ankylosing Spondylitis (AS) | adults | adults |
Crohn’s Disease (CD) | patients 6 years of age and older | patients 6 years of age and older |
Ulcerative Colitis (UC) | patients 5 years of age and older | adults |
Plaque Psoriasis (Ps) | adults | adults |
Hidradenitis Suppurativa (HS) | patients 12 years of age and older | adults |
Uveitis (UV) | patients 2 years of age and older | adults |
Cyltezo is an interchangeable biosimilar to Humira. A biosimilar with an Interchangeable designation can be auto-substituted by a pharmacist for the reference product.
Cyltezo and Humira are both administered via subcutaneous injection.
- Cyltezo is available as a single-dose prefilled syringe and a single dose prefilled pen
- Humira is available as a single-dose prefilled pen, prefilled syringe, and single-dose vial.
See What Are Biosimilars? Top Facts You May Not Know
Related questions
References
- U.S. Food and Drug Administration. HUMIRA Product Label. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125057s417lbl.pdf [Accessed September 20, 2023]
- U.S. Food and Drug Administration. CYLTEZO Product Label. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761058s018lbl.pdf [Accessed September 20, 2023]
- U.S. Food and Drug Administration. What is a Biosimilar? Available at https://www.fda.gov/media/108905/download [Accessed March 2, 2021]
Read next
Does Humira cause weight gain or weight loss?
The manufacturer of Humira does not list weight gain or weight loss as a possible direct side effect associated Humira. However, other conditions, symptoms, or medications may affect your weight while you are using this medication. Clinical studies have also shown weight gain with Humira. Continue reading
How long does it take for Humira to work?
Most patients will start to feel relief from their symptoms within 2 to 12 weeks. Your results will vary based on your condition being treated and other factors, such as tolerability to treatment and other medications you may be using. Continue reading
What food should I avoid while taking Humira?
There are no known interactions between Humira (adalimumab) and food. Most patients should be able to safely follow their normal eating and drinking habits while taking Humira. Continue reading
Related medical questions
- How long can Humira be out of the fridge?
- What are monoclonal antibodies?
- How long can you stay on Humira?
- What are biosimilar drugs and how do they compare to biologics?
- Can you drink alcohol while taking Humira?
- Can I take Humira after covid vaccine?
- Can you take Humira with antibiotics?
- How do you inject Humira?
- Is Humira an immunosuppressant?
- Cosentyx vs Humira: How do they compare?
- What's the difference between Cimzia and Humira?
- Does Humira cause muscle spasms?
- Is Humira good for treating hidradenitis suppurativa?
- Skyrizi vs Humira for plaque psoriasis - How do they compare?
- Is Amjevita interchangeable with Humira?
- Who are the actors in the Humira commercial?
- What are the new drugs for plaque psoriasis?
- What biosimilars have been approved in the United States?
- What are biologic drugs and how do they work?
- What causes Plaque Psoriasis?
- Does Humira make you feel tired?
- Does Humira cause hair loss?
- Humira and Pregnancy: What should I know?
- What is the difference between Amjevita and Humira?
Drug information
Related support groups
- Humira (69 questions, 369 members)
- Adalimumab (14 questions, 14 members)
- Cyltezo (6 questions, 3 members)
- Rheumatoid Arthritis (323 questions, 1,318 members)
- Plaque Psoriasis (86 questions, 69 members)
- Psoriatic Arthritis (83 questions, 278 members)
- Ulcerative Colitis (64 questions, 186 members)
- Crohn's Disease (51 questions, 284 members)
- Juvenile Idiopathic Arthritis (19 questions, 17 members)